181 related articles for article (PubMed ID: 37726373)
1. Effect of functional resistance training on the structure and function of the heart and liver in patients with non-alcoholic fatty liver.
Jafarikhah R; Damirchi A; Rahmani Nia F; Razavi-Toosi SMT; Shafaghi A; Asadian M
Sci Rep; 2023 Sep; 13(1):15475. PubMed ID: 37726373
[TBL] [Abstract][Full Text] [Related]
2. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
[No Abstract] [Full Text] [Related]
3. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.
Zelber-Sagi S; Buch A; Yeshua H; Vaisman N; Webb M; Harari G; Kis O; Fliss-Isakov N; Izkhakov E; Halpern Z; Santo E; Oren R; Shibolet O
World J Gastroenterol; 2014 Apr; 20(15):4382-92. PubMed ID: 24764677
[TBL] [Abstract][Full Text] [Related]
4. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
5. Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease.
Moradi Kelardeh B; Rahmati-Ahmadabad S; Farzanegi P; Helalizadeh M; Azarbayjani MA
J Bodyw Mov Ther; 2020 Jul; 24(3):154-160. PubMed ID: 32825982
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
Zimmermann E; Anty R; Tordjman J; Verrijken A; Gual P; Tran A; Iannelli A; Gugenheim J; Bedossa P; Francque S; Le Marchand-Brustel Y; Clement K; Van Gaal L; Sørensen TIA; Jess T
J Hepatol; 2011 Sep; 55(3):660-665. PubMed ID: 21238518
[TBL] [Abstract][Full Text] [Related]
7. Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
Loomba R; Morgan E; Watts L; Xia S; Hannan LA; Geary RS; Baker BF; Bhanot S
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):829-838. PubMed ID: 32553151
[TBL] [Abstract][Full Text] [Related]
8. Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.
Targher G; Mantovani A; Grander C; Foco L; Motta B; Byrne CD; Pramstaller PP; Tilg H
Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3464-3473. PubMed ID: 34627696
[TBL] [Abstract][Full Text] [Related]
9. Echocardiography and NAFLD (non-alcoholic fatty liver disease).
Trovato FM; Martines GF; Catalano D; Musumeci G; Pirri C; Trovato GM
Int J Cardiol; 2016 Oct; 221():275-9. PubMed ID: 27404689
[TBL] [Abstract][Full Text] [Related]
10. Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease.
Shalimar ; Kumar R; Rout G; Kumar R; Yadav R; Das P; Aggarwal S; Gunjan D; Saraya A; Nayak B
Indian J Gastroenterol; 2020 Feb; 39(1):32-41. PubMed ID: 32185692
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Structure and Function in Patients With Obesity and Non-alcoholic Fatty Liver Disease.
Asatullina Z; Sineglazova AV
Cureus; 2023 Aug; 15(8):e43711. PubMed ID: 37724205
[TBL] [Abstract][Full Text] [Related]
12. Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Charatcharoenwitthaya P; Kuljiratitikal K; Aksornchanya O; Chaiyasoot K; Bandidniyamanon W; Charatcharoenwitthaya N
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00316. PubMed ID: 33939383
[TBL] [Abstract][Full Text] [Related]
13. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
Behairy MA; Sherief AF; Hussein HA
Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial.
Soleimani D; Rezaie M; Rajabzadeh F; Gholizadeh Navashenaq J; Abbaspour M; Miryan M; Razmpour F; Ranjbar G; Rezvani R; Jarahi L; Hashemy SI; Goshayeshi L; Nematy M
Phytother Res; 2021 Mar; 35(3):1669-1679. PubMed ID: 33166032
[TBL] [Abstract][Full Text] [Related]
16. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.
Hashida R; Kawaguchi T; Bekki M; Omoto M; Matsuse H; Nago T; Takano Y; Ueno T; Koga H; George J; Shiba N; Torimura T
J Hepatol; 2017 Jan; 66(1):142-152. PubMed ID: 27639843
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease.
Yeniova AO; Küçükazman M; Ata N; Dal K; Kefeli A; Başyiğit S; Aktaş B; Ağladioğlu K; Akin KO; Ertugrul DT; Nazligül Y; Beyan E
Hepatogastroenterology; 2014; 61(130):422-5. PubMed ID: 24901154
[TBL] [Abstract][Full Text] [Related]
18. The benefits of exercise for patients with non-alcoholic fatty liver disease.
Keating SE; George J; Johnson NA
Expert Rev Gastroenterol Hepatol; 2015; 9(10):1247-50. PubMed ID: 26289101
[TBL] [Abstract][Full Text] [Related]
19. Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study.
Bhatt SP; Misra A; Nigam P; Guleria R; Pasha MA
PLoS One; 2015; 10(11):e0142260. PubMed ID: 26599361
[TBL] [Abstract][Full Text] [Related]
20. The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial.
Yurtdaş G; Akbulut G; Baran M; Yılmaz C
Pediatr Obes; 2022 Apr; 17(4):e12872. PubMed ID: 34881510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
